| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Adult and child malaria mortality in India: a nationally representative mortality survey.
|
Lancet
|
2010
|
7.89
|
|
2
|
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.
|
Emerg Infect Dis
|
2007
|
6.75
|
|
3
|
Antimicrobial resistance in developing countries. Part I: recent trends and current status.
|
Lancet Infect Dis
|
2005
|
5.58
|
|
4
|
Non-prescription antimicrobial use worldwide: a systematic review.
|
Lancet Infect Dis
|
2011
|
3.54
|
|
5
|
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development.
|
Lancet Infect Dis
|
2002
|
3.46
|
|
6
|
Rationalizing antibiotic use to limit antibiotic resistance in India.
|
Indian J Med Res
|
2011
|
2.36
|
|
7
|
Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis.
|
Lancet
|
2010
|
2.23
|
|
8
|
Benefits of using multiple first-line therapies against malaria.
|
Proc Natl Acad Sci U S A
|
2008
|
2.13
|
|
9
|
Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia.
|
Arch Intern Med
|
2010
|
2.11
|
|
10
|
Antimicrobial resistance in developing countries. Part II: strategies for containment.
|
Lancet Infect Dis
|
2005
|
2.05
|
|
11
|
Strategic interactions in multi-institutional epidemics of antibiotic resistance.
|
Proc Natl Acad Sci U S A
|
2005
|
1.92
|
|
12
|
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease?
|
Infect Control Hosp Epidemiol
|
2011
|
1.83
|
|
13
|
The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study.
|
Am J Epidemiol
|
2013
|
1.67
|
|
14
|
Optimal control of epidemics in metapopulations.
|
J R Soc Interface
|
2009
|
1.58
|
|
15
|
Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006.
|
Emerg Infect Dis
|
2009
|
1.56
|
|
16
|
Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis.
|
Health Econ
|
2014
|
1.54
|
|
17
|
Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers.
|
Infect Control Hosp Epidemiol
|
2011
|
1.49
|
|
18
|
The Affordable Medicines Facility--malaria: killing it slowly.
|
Lancet
|
2012
|
1.47
|
|
19
|
Seasonality and temporal correlation between community antibiotic use and resistance in the United States.
|
Clin Infect Dis
|
2012
|
1.43
|
|
20
|
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients.
|
PLoS One
|
2011
|
1.37
|
|
21
|
A sticky situation: the unexpected stability of malaria elimination.
|
Philos Trans R Soc Lond B Biol Sci
|
2013
|
1.32
|
|
22
|
A framework for global surveillance of antibiotic resistance.
|
Drug Resist Updat
|
2011
|
1.29
|
|
23
|
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010.
|
Infect Control Hosp Epidemiol
|
2013
|
1.27
|
|
24
|
Synthesizing epidemiological and economic optima for control of immunizing infections.
|
Proc Natl Acad Sci U S A
|
2011
|
1.27
|
|
25
|
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
|
Malar J
|
2008
|
1.23
|
|
26
|
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.
|
Malar J
|
2010
|
1.20
|
|
27
|
Financing health improvements in India.
|
Health Aff (Millwood)
|
2008
|
1.14
|
|
28
|
Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.
|
BMC Public Health
|
2013
|
1.11
|
|
29
|
Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006.
|
Infect Control Hosp Epidemiol
|
2010
|
1.09
|
|
30
|
"One-size-fits-all"? Optimizing treatment duration for bacterial infections.
|
PLoS One
|
2012
|
1.05
|
|
31
|
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
|
Trop Med Int Health
|
2009
|
1.01
|
|
32
|
The unsurprising story of MDR-TB resistance in India.
|
Tuberculosis (Edinb)
|
2012
|
0.95
|
|
33
|
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
|
Emerg Infect Dis
|
2015
|
0.94
|
|
34
|
Unit cost of medical services at different hospitals in India.
|
PLoS One
|
2013
|
0.93
|
|
35
|
Superinfection and the evolution of resistance to antimalarial drugs.
|
Proc Biol Sci
|
2012
|
0.92
|
|
36
|
The Socioeconomic and Institutional Determinants of Participation in India's Health Insurance Scheme for the Poor.
|
PLoS One
|
2013
|
0.92
|
|
37
|
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012.
|
Antimicrob Agents Chemother
|
2013
|
0.89
|
|
38
|
Cost-effectiveness of "golden mustard" for treating vitamin A deficiency in India.
|
PLoS One
|
2010
|
0.85
|
|
39
|
Economic issues and antibiotic resistance in the community.
|
Ann Pharmacother
|
2002
|
0.84
|
|
40
|
Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis.
|
Infect Control Hosp Epidemiol
|
2011
|
0.83
|
|
41
|
Costs of surgical procedures in Indian hospitals.
|
BMJ Open
|
2013
|
0.83
|
|
42
|
Postgraduate education in nutrition in south Asia: a huge mismatch between investments and needs.
|
BMC Med Educ
|
2014
|
0.82
|
|
43
|
Is methicillin-susceptible Staphylococcus aureus (MSSA) sequence type 398 confined to Northern Manhattan? Rising prevalence of erythromycin- and clindamycin-resistant MSSA clinical isolates in the United States.
|
Clin Infect Dis
|
2013
|
0.81
|
|
44
|
Respiratory fluoroquinolone use and influenza.
|
Infect Control Hosp Epidemiol
|
2011
|
0.81
|
|
45
|
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections.
|
Antimicrob Resist Infect Control
|
2013
|
0.80
|
|
46
|
Reinvesting in health post-2015.
|
Lancet
|
2013
|
0.79
|
|
47
|
East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States.
|
Infect Control Hosp Epidemiol
|
2013
|
0.79
|
|
48
|
Are physicians' prescribing decisions sensitive to drug prices? Evidence from a free-antibiotics program.
|
Health Econ
|
2013
|
0.77
|
|
49
|
The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence.
|
Future Microbiol
|
2013
|
0.76
|
|
50
|
Diversify or focus? Spending to combat infectious diseases when budgets are tight.
|
J Health Econ
|
2012
|
0.75
|
|
51
|
Resistance movement: Hospital administrators must join the fight against antibiotic overuse.
|
Mod Healthc
|
2012
|
0.75
|